Study S000944

Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06154486
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 30
Start: 2023-06-19
Primary completion: 2023-06-19
Lead sponsor: Hospital Israelita Albert Einstein
Conditions: Pneumonia, Aspiration; Anesthesia
Interventions: DRUG:semaglutide use
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

prevalence of full stomach after fasting for at least 8 hours [1 day]

Linked records (3)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0005852	Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs). Kalra S, Diabetes therapy : research, treatment and education of diabetes and related disorders	2021	Narrative review	PMID 34268675 DOI	registry reference BACKGROUND:34268675
R0023553	Gastroparesis With the Initiation of Liraglutide: A Case Report. Almustanyir S, Cureus	2020	Case report	PMID 33403167 DOI	registry reference BACKGROUND:33403167
R0022992	Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial. Halawi H, The lancet. Gastroenterology & hepatology	2017	Randomized trial	PMID 28958851 DOI	registry reference BACKGROUND:28958851